Israel will begin offering a third shot of the Pfizer-BioNTech Covid-19 vaccine to people over 60, Israel's Kan public radio and Channel 13 TV say.
it believes people need a third dose to keep protection against the coronavirus high. The company says it could apply for U.S. emergency authorization for booster shots as early as August.
Kan and Channel 13 said the director-general of Israel's health ministry informed the heads of health maintenance organizations that have been administering the two-dose Pfizer vaccine that they could provide, as of Sunday, booster shots for people over the age of 60. The ministry said earlier that it would make an official announcement about a booster campaign later in the day.
Since the delta variant began spreading in Israel in June, the health ministry has twice reported a drop in the vaccine's effectiveness against infection and a slight decrease in its protection against severe disease.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Israel Begins Pfizer Covid-19 Vaccine for At-Risk Children Under 12 as Delta Cases SurgeThe country has authorized the use of Pfizer’s Covid-19 vaccine for vulnerable children between five and 11 years old, as cases of the highly contagious Delta variant rise sharply.
Consulte Mais informação »
Citing New Data, Pfizer Outlines Case for Booster ShotsPfizer offered new evidence on Wednesday in support of booster shots of its potent vaccine, reporting that the vaccine’s power wanes slightly over time but may be improved with a third dose. The new data, which have not yet been peer-reviewed nor published in a scientific journal, nonetheless confirm that the two-dose vaccine offers potent protection against the coronavirus. Whether booster shots will be widely needed is far from settled, the subject of heated debate among scientists. So far, fe
Consulte Mais informação »
Pfizer data suggest third dose of Covid-19 vaccine 'strongly' boosts protection against Delta variantA third dose of the Pfizer/BioNTech Covid-19 vaccine can 'strongly' boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday.
Consulte Mais informação »
Pfizer Raises Full-Year Outlook on Covid-19 Vaccine SalesThe pharmaceutical company’s Covid-19 vaccine co-developed with BioNTech contributed $7.8 billion to Pfizer’s total sales of $18.98 billion in the latest quarter.
Consulte Mais informação »
Stocks making the biggest moves premarket: McDonald's, Boeing, Pfizer, Spotify and moreThese are the stocks posting the largest moves before the bell.
Consulte Mais informação »
Pfizer Vaccine Protection Wanes After 6 Months Study FindsPfizer’s COVID-19 vaccine continues to show strong protection against serious illness and hospitalization after 6 months, but overall protection against the virus appears to wane after a half a year, according to a new study.
Consulte Mais informação »